» Articles » PMID: 17412982

Genetic Diversity in Hepatitis C Virus in Egypt and Possible Association with Hepatocellular Carcinoma

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2007 Apr 7
PMID 17412982
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Egypt has one of the world's highest prevalences of hepatitis C virus (HCV) infection, with a majority of genotype 4 infections. To explore the genetic diversity of HCV in Egypt, sera from 131 Egyptians [56 from community studies, 37 chronic hepatitis patients, 28 hepatocellular carcinoma (HCC) patients and 10 patients with non-Hodgkin's lymphoma] were genotyped by restriction fragment-length polymorphism and phylogenetic analyses of sequences from the mid-core and non-structural 5B regions. The different genotyping methods showed good agreement. The majority of the viruses (83 of 131; 63%) were of subtype 4a, but five other subtypes within genotype 4 were also observed, as well as three genotype 1b, five genotype 1g and one genotype 3a samples. Interestingly, subtype 4o, which was easily identifiable in all three genomic regions, showed an association with HCC (P=0.017), which merits further investigation.

Citing Articles

The challenge of treating hepatitis C virus infection in children with comorbidities.

Mogahed E, Nabil N, Ghita H, Enayet A, El-Karaksy H Eur J Pediatr. 2025; 184(3):235.

PMID: 40063124 PMC: 11893629. DOI: 10.1007/s00431-025-06038-3.


Circulating microRNAs as potential biomarkers of physical activity in geriatric patients with HCV.

Al-Rawaf H, Gabr S, Iqbal A, Alghadir A BMC Mol Cell Biol. 2024; 25(1):18.

PMID: 39030480 PMC: 11264506. DOI: 10.1186/s12860-024-00514-8.


Incidence Trends of Cancer in Morocco: The Tale of the Oncological Center of Marrakech (Morocco) over 8 Years.

Belbaraka R, Benhima N, Laatabi A, El Fadli M, Essadi I J Cancer Epidemiol. 2022; 2022:3307194.

PMID: 35265131 PMC: 8901288. DOI: 10.1155/2022/3307194.


Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.

Ahmed H, Waly N, Abd El-Baky R, Yahia R, Hetta H, Elsayed A PLoS One. 2021; 16(4):e0249770.

PMID: 33857212 PMC: 8049381. DOI: 10.1371/journal.pone.0249770.


Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patients.

El-Tahan R, Ghoneim A, Zaghloul H Virus Genes. 2020; 56(5):564-581.

PMID: 32572756 PMC: 7307947. DOI: 10.1007/s11262-020-01776-y.